Yes, drug R&D is difficult, costly and risky. But these factors don’t really justify a high price. Value does.
Subscribe to:
Post Comments (Atom)
< + > Evogene – Can a Platform Company Become a Real Business? – Life Sciences Today Podcast Episode 74
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gabi Tarcic, Chie...
No comments:
Post a Comment